Preston Klassen Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Preston Klassen.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Preston Klassen. Preston Klassen is EVP and CMO in ARENA PHARMACEUTICALS INC ($ARNA) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and EVP, Global Development in Orexigen Therapeutics, Inc. ($OREX) and SVP, Head Global Development in Orexigen Therapeutics, Inc. ($OREX) and President & CEO in Metacrine, Inc. ($MTCR).

Latest Insider Trading Transactions of Preston Klassen

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARNA, HSTO, MTCR, OREX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 12 2021	MTCR	Metacrine, Inc.	Klassen Preston	President & CEO	Option Exercise	A	10.09	247,500	2,497,275	247,500
Oct 16 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	M	0.00	6,300	0	18,900
Oct 16 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Payment of Exercise	F	47.32	2,309	109,262	3,991	6.3 K to 4 K (-36.65 %)
Oct 16 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Buy	M	0.00	6,300	0	6,300	0 to 6.3 K
Jul 01 2019	CNAT	Conatus Pharmaceut ...	Klassen Preston	Director	Option Exercise	A	0.29	20,000	5,800	20,000
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	M	15.10	3,000	45,300	110,350
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	M	15.10	3,000	45,300	110,350
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	M	15.10	16,000	241,600	113,350
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	M	15.10	16,000	241,600	113,350
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	0.00	12,600	0	12,600
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	0.00	12,600	0	12,600
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	40.94	75,000	3,070,500	75,000
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	40.94	75,000	3,070,500	75,000
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	44.00	3,000	132,000	0	3 K to 0 (-100.00 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	44.00	3,000	132,000	0	3 K to 0 (-100.00 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Buy	M	15.10	3,000	45,300	3,000	0 to 3 K
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Buy	M	15.10	3,000	45,300	3,000	0 to 3 K
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	42.32	400	16,927	0	400 to 0 (-100.00 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	42.32	400	16,927	0	400 to 0 (-100.00 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	41.68	15,600	650,139	400	16 K to 400 (-97.50 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Sell	S	41.68	15,600	650,139	400	16 K to 400 (-97.50 %)
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Buy	M	15.10	16,000	241,600	16,000	0 to 16 K
Jan 08 2019	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Buy	M	15.10	16,000	241,600	16,000	0 to 16 K
Jun 25 2018	CNAT	Conatus Pharmaceut ...	Klassen Preston	Director	Option Exercise	A	4.99	20,000	99,800	20,000
Jan 22 2018	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	35.60	130,000	4,628,000	130,000
Jun 26 2017	CNAT	Conatus Pharmaceut ...	Klassen Preston	Director	Option Exercise	A	4.96	20,000	99,200	20,000
Mar 20 2017	ARNA	ARENA PHARMACEUTIC ...	Klassen Preston	EVP and CMO	Option Exercise	A	1.50	1,293,500	1,940,250	1,293,500
Jun 24 2016	CNAT	Conatus Pharmaceut ...	Klassen Preston	Director	Option Exercise	A	2.13	20,000	42,600	20,000
Feb 04 2016	OREX	Orexigen Therapeut ...	Klassen Preston	EVP, Global Develop ...	Option Exercise	A	0.00	350,000	0	350,000
Feb 04 2016	OREX	Orexigen Therapeut ...	Klassen Preston	EVP, Global Develop ...	Option Exercise	A	1.78	190,000	338,200	190,000
Feb 04 2016	OREX	Orexigen Therapeut ...	Klassen Preston	EVP, Global Develop ...	Grant	A	2.03	4,170	8,465	10,160	6 K to 10.2 K (+69.62 %)
Feb 04 2016	OREX	Orexigen Therapeut ...	Klassen Preston	EVP, Global Develop ...	Grant	A	4.17	1,860	7,756	5,990	4.1 K to 6 K (+45.04 %)
Jun 15 2015	CNAT	Conatus Pharmaceut ...	Klassen Preston	Director	Option Exercise	A	5.52	15,000	82,800	15,000
Feb 05 2015	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	5.34	182,650	975,351	182,650
Feb 05 2015	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Grant	A	4.92	1,542	7,587	4,130	2.6 K to 4.1 K (+59.58 %)
Feb 05 2015	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Grant	A	5.25	1,318	6,920	2,588	1.3 K to 2.6 K (+103.78 %)
Feb 11 2014	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	6.30	205,000	1,291,500	205,000
Feb 11 2014	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Grant	A	5.34	1,270	6,782	1,270	0 to 1.3 K
Jul 29 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	M	1.66	71,229	118,240	732,000
Jul 29 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Sell	S	7.16	71,229	510,000	0	71.2 K to 0 (-100.00 %)
Jul 29 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Buy	M	1.66	71,229	118,240	71,229	0 to 71.2 K
May 30 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	M	1.66	28,771	47,760	803,229
May 30 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Sell	S	7.21	28,771	207,358	0	28.8 K to 0 (-100.00 %)
May 30 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Buy	M	1.66	28,771	47,760	28,771	0 to 28.8 K
Feb 19 2013	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	5.69	245,000	1,394,050	245,000
Jan 26 2012	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	2.58	350,000	903,000	350,000
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	1.70	450,000	765,000	0
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	2.94	107,000	314,580	0
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	2.94	45,000	132,300	0
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	6.74	30,000	202,200	0
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	7.52	200,000	1,504,000	0
Jul 26 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	1.66	832,000	1,381,120	832,000
Jun 14 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	1.69	450,000	760,500	450,000
Mar 04 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	2.94	107,000	314,580	107,000
Mar 04 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	9.31	107,000	996,170	0
Mar 04 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	2.94	45,000	132,300	45,000
Mar 04 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	D	5.89	45,000	265,050	0
Jan 20 2011	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	9.31	107,000	996,170	107,000
Sep 22 2010	OREX	Orexigen Therapeut ...	Klassen Preston	SVP, Head Global De ...	Option Exercise	A	5.89	45,000	265,050	45,000

Page: 1